F. Hoffmann-La Roche Ltd: Roche renews partnership with Sysmex to deliver haematology testing solutions
This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally
The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience
Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of all central laboratory tests
1
Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP) with Sysmex. Under this new framework, the parties renewed their commitment to the long standing Distribution, Sales and Service (DSS) agreement, allowing Roche to continue to distribute Sysmex haematology products, including instruments and reagents.
Roche renews partnership with Sysmex to deliver haematology testing solutions
Nachrichtenquelle: globenewswire | 25.01.2021, 07:03 | 171
This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally
The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience
Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of all central laboratory tests
1 Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP) with Sysmex. Under this new framework, the parties renewed their commitment to the long standing Distribution, Sales and Service (DSS) agreement, allowing Roche to continue to distribute Sysmex haematology products, includ
Average age of Covid-19 cases in Galway remains lowest nationwide
22 January 2021
Galway based Complete Laboratory Solutions (CLS), Ireland’s largest privately-owned contract laboratory, has launched PCR COVID-19 private testing as part of the expansion of the firm’s clinical laboratory facilities in the west of Ireland. The service is available to both private industry and public health in Ireland. The new molecular laboratories at CLS adhere to the highest industry standards including procedures aligned and complying with ISO 17025. Photo Martina Regan.
print
Galway Bay fm newsroom – The average age of confirmed cases of Covid-19 in Galway remains the lowest nationwide.
Share this article
Share this article
SAN FRANCISCO, Jan. 19, 2021 /PRNewswire/ The global laboratory proficiency testing market size is expected to reach USD 1.9 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.3% from 2020 to 2027. The market is driven by the increasing focus on water tests, legalization of medical cannabis, a growing number of cannabis testing laboratories, and increasing outbreaks of foodborne illnesses.
Government initiatives to carry out accurate and reliable proficiency testing are expected to drive the market. For instance, in October 2020, the Central Testing Laboratory of the Abu Dhabi Quality & Conformity Council implemented a PT program in collaboration with Biogenix Lab to verify the competency of medical laboratories carrying out COVID-19 tests.
Congeladores para vacunas: una compra desconcertante prensa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prensa.com Daily Mail and Mail on Sunday newspapers.